ClinicalTrials.gg
CompletedNCT05735561PHF-DUpdated Sep 13, 2023

Proximal Humerus Fracture Dislocation Direction and Avascular Necrosis

An observational study in Proximal Humeral Fracture, Dislocation and Dislocation Shoulder, sponsored by Fraser Orthopaedic Research Society. Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-13.

Sponsored by Fraser Orthopaedic Research Society · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
25
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the study is to see if there is a connection between a proximal humerus fracture dislocation direction and the likelihood of developing avascular necrosis. Utilizing a retrospective cohort from the last ten years we hope to bring consenting patients back for a single visit to have x-rays and complete patient reported outcome measures to assess for evidence of avascular necrosis.

Read the detailed description

The incidence of proximal humerus fractures continues to increase and is among one of the more common fractures seen in the adult population. Proximal humerus fracture dislocations, however, are less common. Despite the decreased prevalence, fracture dislocations have unique challenges with respect to obtaining an anatomical reduction and more frequently involve an open surgical reduction. In addition, depending on other fracture characteristics, there are various treatment options for the fracture itself. While fracture dislocations ultimately lead to increased AVN and revision surgery, further discussion surrounding the direction of dislocation and how it may influence overall outcomes has not been addressed in the previous literature. The study design utilizes a retrospective cohort from the last ten years, by asking patients who have had a previously surgically treated proximal humerus fracture dislocations to come back to the surgeon's private clinic to complete a single visit assessment. During this assessment the consenting participant will receive x-rays and complete patient reported outcome measures. In conjunction, these will be utilized to assess overall function and the existence of avascular necrosis.

02

Conditions studied

  • Proximal Humeral Fracture
  • Dislocation
  • Dislocation Shoulder
  • Avascular Necrosis
  • Avascular Necrosis of Humerus
03

In context

Shoulder Fractures

109 studies on the registry are indexed under Shoulder Fractures; 27 are open to participants now.

This study's enrollment of 25 is below the median of 94 across 55 observational studies indexed under Shoulder Fractures.

Browse Shoulder Fractures studies →

Lead sponsor

Fraser Orthopaedic Research Society is the lead sponsor of 10 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Skeletally mature patients who were surgically treated for their proximal humerus fracture dislocation between 2011 and 2021.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients 18 years of age or older
  • Patients who underwent operative fixation of proximal humerus fracture dislocation at Royal Columbian Hospital between January 2011 and July 2021
  • Willing and able to consent and complete patient reported outcome measures
  • Willing and able to follow the protocol and attend a follow-up visit
  • Able to read and understand English or have an interpreter available

Exclusion criteria

Exclusion Criteria:

  • Skeletally immature patients
  • Patient with pathological fractures
  • Patients who have had previous operative fixation of proximal humerus
  • Patients treated non-operatively
  • patients presenting outside of the study duration window
  • Patients treated by a non-participating surgeon
  • Deceased patients
  • Patients unable to complete patient reported outcome measures
  • Patients declining to come back to the clinic for updated x-rays
  • Dementia
  • Incarceration
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
25 participants (actual)
Patient registry
No

Groups and cohorts

  • Proximal Humerus Fracture Anterior Dislocation

    The study doesn't provide any intervention. This group is defined as having a dislocation that is anterior to the glenoid.

  • Proximal Humerus Fracture Posterior Dislocation

    The study doesn't provide any intervention. This group is defined as having a dislocation that is posterior to the glenoid.

    Diagnostic Test: X-Ray

  • Proximal Humerus Fracture Varus Dislocation

    The study doesn't provide any intervention. This group is defined as having a dislocation that is in varus compared to the glenoid.

    Diagnostic Test: X-Ray

  • Proximal Humerus Fracture Valgus Dislocation

    The study doesn't provide any intervention. This group is defined as having a dislocation that is in valgus compared to the gelnoid.

    Diagnostic Test: X-Ray

Interventions

  • Diagnostic testX-Ray

    Consenting participants will be asked to come into the clinic for a single visit, during this visit they will be asked to complete an x-ray to check for evidence of avascular necrosis.

06

What researchers measure

Primary outcomes

  1. Rates of Avascular Necrosis

    The presence and advancement of avascular necrosis (as classified by the Cruess Classification System) and as assessed on radiographs.

    Time frame: At least 2 years post fracture fixation

  2. Direction of the Humeral Fracture Dislocation

    As characterized by the direction of the humeral head in relation to the glenoid, based on AP, Lateral, or Axillary x-ray views.

    Time frame: At least 2 years post fracture fixation

Secondary outcomes

  1. DASH (functional outcome)

    Asking participants to complete the Disabilities of the Arm, Shoulder, and Hand outcome measure as a way of assessing function.

    Time frame: At least 2 years post fracture fixation

  2. Constant Score (functional outcome)

    Asking participants to complete the Constant Score patient reported outcome measure as a way of assessing participant function.

    Time frame: At least 2 years post fracture fixation

07

Study locations

1 site
  • Royal Columbian Hospital/Fraser Health Authority
    New Westminster, British Columbia V3L 3W7, Canada
08

References and documents

Publications

  • Schumaier A, Grawe B. Proximal Humerus Fractures: Evaluation and Management in the Elderly Patient. Geriatr Orthop Surg Rehabil. 2018 Jan 25;9:2151458517750516. doi: 10.1177/2151458517750516. eCollection 2018. PubMed 29399372 ↗
  • Greiner S, Kaab MJ, Haas NP, Bail HJ. Humeral head necrosis rate at mid-term follow-up after open reduction and angular stable plate fixation for proximal humeral fractures. Injury. 2009 Feb;40(2):186-91. doi: 10.1016/j.injury.2008.05.030. Epub 2008 Dec 18. PubMed 19100544 ↗
  • Hertel R, Hempfing A, Stiehler M, Leunig M. Predictors of humeral head ischemia after intracapsular fracture of the proximal humerus. J Shoulder Elbow Surg. 2004 Jul-Aug;13(4):427-33. doi: 10.1016/j.jse.2004.01.034. PubMed 15220884 ↗
  • Boesmueller S, Wech M, Gregori M, Domaszewski F, Bukaty A, Fialka C, Albrecht C. Risk factors for humeral head necrosis and non-union after plating in proximal humeral fractures. Injury. 2016 Feb;47(2):350-5. doi: 10.1016/j.injury.2015.10.001. Epub 2015 Oct 22. PubMed 26706457 ↗
  • Miltenberg B, Masood R, Katsiaunis A, Moverman MA, Puzzitiello RN, Pagani NR, Menendez ME, Salzler MJ, Drager J. Fracture dislocations of the proximal humerus treated with open reduction and internal fixation: a systematic review. J Shoulder Elbow Surg. 2022 Oct;31(10):e480-e489. doi: 10.1016/j.jse.2022.04.018. Epub 2022 May 20. PubMed 35605847 ↗
  • Cruess RL, Blennerhassett J, MacDonald FR, MacLean LD, Dossetor J. Aseptic necrosis following renal transplantation. J Bone Joint Surg Am. 1968 Dec;50(8):1577-90. No abstract available. PubMed 4881164 ↗

Study documents

  • Study protocol · Jan 9, 2023
  • Informed consent form · Jan 24, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — There is currently no plan to share individual participant data with other researchers, results will of course be shared. However, the hope is that the study might indicate a need for a high powered prospective clinical trial to be completed.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2023 to primary completion in Jul 2023, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 27, 2023
First posted
Feb 21, 2023
StartActual
Feb 15, 2023
Primary completionActual
Jul 31, 2023
CompletionActual
Aug 31, 2023
Last update
Sep 13, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05735561
Lead sponsor
Fraser Orthopaedic Research Society
Responsible party
Sponsor
First posted
Feb 21, 2023
Start date
Feb 15, 2023
Primary completion
Jul 31, 2023
Completion
Aug 31, 2023
Last update
Sep 13, 2023

Study contacts

Farhad Moola, MD
principal investigator · FHA Orthopaedic Surgeon

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion